BAO PHARMA-B (02659.HK) -0.380 (-1.526%) issued a statement regarding unusual movements in its share price and trading volume, confirming that it is not aware of any reasons causing such volatility. The company also confirmed that its business operations remain normal and that there have been no material changes to its business operations or financial position. At the same time, it proposed a share repurchase of up to 10% of the total number of H shares.In addition, Dr. Liu Yanjun, chairman and controlling shareholder of the group, intends to increase his shareholding in the company within three months from today. The maximum number of shares to be acquired will not exceed 38.8939 million shares.The stock closed at HKD25.8 on the previous trading day (30th), down HKD49.1 or 65.55%, with a trading volume of 26 million shares and turnover of HKD785 million. (de/d)(HK stocks quote is delayed for at least 15 mins.)
AASTOCKS Financial News